Sangoma Technologies (SANG) EBITDA (2020 - 2026)

Sangoma Technologies' EBITDA history runs 7 years deep, the most recent figure standing at $18.0 million for Q1 2026.

• On a quarterly basis, EBITDA fell 11.53% year-over-year to $18.0 million in Q1 2026; TTM through Mar 2026 was $54.6 million, a 9.0% decrease from a year earlier, with the FY2025 full-year figure at $41035.0, down 3.66% from the prior year.
• EBITDA eased to $18.0 million in Q1 2026 per SANG's latest filing, from $18.9 million in the prior quarter.
• Across five years, EBITDA topped out at $11.1 billion in Q4 2022 and bottomed at $11110.0 in Q2 2024.
• The 5-year median for EBITDA is $19.9 million (2024), against an average of $671.6 million.
• Across the five-year window, EBITDA jumped 106591.59% in 2022 and slumped 99.95% in 2024, its largest moves.
• Year by year, EBITDA stood at $11.1 billion in 2022, then slumped by 99.81% to $21.1 million in 2023, then declined by 6.53% to $19.7 million in 2024, then declined by 4.35% to $18.9 million in 2025, then slipped by 4.87% to $18.0 million in 2026.
• Per Business Quant, the three latest SANG EBITDA figures stand at $18.0 million (Q1 2026), $18.9 million (Q4 2025), and $17.7 million (Q3 2025).